Chong Xu
Partner·F-Prime
Cambridge, MA, USA
Chong Xu is a Partner at F-Prime focused primarily on biopharmaceutical and medical technology investments. He works with Eight Roads Ventures Asia on portfolio companies and new investment opportunities in China, and has been involved in company formations including AlphaGen Tx, Pediatrix, Skyline Tx, K36 Tx, and RareStone Group. Before joining F-Prime in 2015, he worked at McKinsey, as a healthcare equity analyst at Massif Partners and Affirmed Healthcare, and as a developmental neurobiology researcher at Temasek Life Sciences Laboratory.
See the rest of Chong Xu's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.